Xenetic Biosciences, Inc. (XBIO) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -536.38K | -242.68K | -658.25K | -383.83K | -1M | -673.99K | -459.04K | -525.1K | -1.16M | -793.03K | -949.63K | -1.27M | -1.1M | -750.91K | -1.08M | -728.9K | -2.09M | -1.46M | -1.03M | -726.81K |
| Operating CF Margin % | -66.47% | -31.67% | -64.1% | -65.07% | -168.88% | -103.88% | -74.73% | -72.29% | -226.96% | -118.02% | -155.38% | -194.95% | -181.97% | -154.2% | -260.54% | -174.92% | -536.69% | -438.57% | -295.87% | -252.71% |
| Operating CF Growth % | 46.46% | 63.99% | -43.4% | 26.9% | 13.58% | 15.01% | 51.66% | 58.62% | -5.16% | -5.61% | 12.01% | -74.11% | 47.19% | 48.52% | -4.44% | -0.29% | -37.42% | -52.96% | -2.1% | 44.12% |
| Net Income | -456.38K | -579.08K | -509.94K | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.06M | -1.05M | -856.55K | -1.48M | -804.02K | -2.67M | -1.59M | -1.84M | -1.35M | -1.11M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.96K | 9.61K | 9.47K | 9.28K | 9.04K | 8.75K |
| Stock-Based Compensation | 0 | 14K | 0 | 15.68K | 19.25K | 25.11K | 27.54K | 42.1K | 77.07K | 74.58K | 70.27K | 69.39K | 68.85K | 118.65K | 137.36K | 135.87K | 119.59K | 113.1K | 111.13K | 109.92K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -381.6K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 11.31K | 0 | 15.85K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 488.75K | 381.6K | 1.3M | 0 | 0 | 0 | 0 |
| Working Capital Changes | -91.31K | 322.4K | -164.16K | 289.19K | -118K | 355.42K | -49.9K | 706.77K | -41.31K | 303.9K | 35.66K | -287.55K | -314.74K | 124.23K | -420.57K | 492.81K | -623.15K | 260.6K | 197.34K | 261.2K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -9.79K | -143.75K | 208.34K | 235.5K | -226.34K | -115.14K | -578.2K | 871.11K | -93.09K | -258.91K | 197.18K | 14.95K | -216.79K | 22.3K | -228.32K | 215.91K | -357.83K | 299.61K | 155.32K | 150.41K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -500K | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | 0% | - | 0% | - | 0% | - | - | - | - | - | 0% | - | 0% | - | - | 0% | - | 0% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -500K | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.45M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.45M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -536.38K | 3.76M | -658.25K | -383.83K | -1M | -673.99K | -459.04K | -525.1K | -1.16M | -793.03K | -949.63K | -1.27M | -1.1M | -750.91K | -1.08M | -1.23M | -2.09M | -1.46M | 10.42M | -726.81K |
| Free Cash Flow | -536.38K | -242.68K | -658.25K | -383.83K | -1M | -673.99K | -459.04K | -525.1K | -1.16M | -793.03K | -949.63K | -1.27M | -1.1M | -750.91K | -1.08M | -728.9K | -2.09M | -1.46M | -1.03M | -726.81K |
| FCF Margin % | -66.47% | -31.67% | -64.1% | -65.07% | -168.88% | -103.88% | -74.73% | -72.29% | -226.96% | -118.02% | -155.38% | -194.95% | -181.97% | -154.2% | -260.54% | -174.92% | -536.69% | -438.57% | -295.87% | -252.71% |
| FCF Growth % | 46.46% | 63.99% | -43.4% | 26.9% | 13.58% | 15.01% | 51.66% | 58.62% | -5.16% | -5.61% | 12.01% | -74.11% | 47.19% | 48.52% | -4.44% | -0.29% | -37.42% | -52.96% | -2.1% | 44.12% |
| FCF per Share | -0.23 | -0.11 | -0.43 | -0.25 | -0.65 | -0.44 | -0.30 | -0.34 | -0.75 | -0.52 | -0.62 | -0.83 | -0.73 | -0.50 | -0.85 | -0.57 | -1.64 | -1.43 | -1.02 | -0.83 |
| FCF Conversion (FCF/Net Income) | 1.18x | 0.42x | 1.29x | 0.56x | 1.11x | 0.64x | 1.05x | 0.41x | 0.97x | 0.68x | 0.90x | 1.21x | 1.29x | 0.51x | 1.34x | 0.27x | 1.31x | 0.79x | 0.76x | 0.66x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |